UCP1 is activated by fatty acids and inhibited by purine nucleotides, but precisely how this regulation occurs remains unsettled. Although fatty acids can competitively overcome nucleotide inhibition in functional assays, fatty acids have little effect on purine nucleotide binding.
Here we present the first demonstration that fatty acids induce a conformational change in UCP1. Palmitate dramatically changed the binding kinetics of mant-GDP, a fluorescently labeled nucleotide analog, to UCP1. Furthermore, palmitate accelerated the rate of enzymatic proteolysis of UCP1. The altered kinetics of both processes indicate that fatty acids change the conformation of UCP1, reconciling the apparent discrepancy between existing functional and ligand binding data. Our results provide a framework for how fatty acids and
INTRODUCTION
Uncoupling protein 1 (UCP1) 5 dissipates the mitochondrial protonmotive force that couples substrate oxidation to ATP synthesis (1,2). UCP1 facilitates non-shivering thermogenesis in brown adipose tissue (BAT), short-circuiting the chemiosmotic process to increase the rate of heat generation (3) . The protein is also functionally expressed in the rodent thymus (4, 5) and carp liver mitochondria (6) , where its role is likely attenuation of reactive oxygen species production rather than heat production (7) .
Concerted regulation of UCP1 is exerted at the levels of catalytic activity, transcription, and mitochondrial turnover (8) . Activation of the protein by free fatty acids and inhibition by purine nucleoside di-and triphosphates has been known for decades (9) . However, the explicit mechanism of this acute regulation remains contentious and unresolved.
Three competing models seek to describe catalysis of proton transport by UCP1: i) fatty acids are obligatory cofactors for proton transport, embedding their carboxyl side-chains into the core of the protein to buffer protons (10, 11) , ii) UCP1 facilitates a protonophoric cycle by translocating fatty acid anions across the mitochondrial inner membrane (12, 13) , and iii) fatty acids and nucleotides functionally compete to regulate UCP1-catalyzed proton leak (14) .
The functional competition model is likely the most physiologically relevant of the three, as it is informed by studies of the native protein in isolated mitochondria from BAT. Conversely, the first two models rely primarily on data from UCP1 reconstituted into proteoliposomes, a system that produces results that are sometimes inconsistent with those from mitochondria (15) .
The functional competition model, however, fits poorly with the longstanding observation that fatty acids have little effect on the binding of nucleotides to UCP1 (9, 11, 16) . This uncovers a glaring question regarding the mechanism of UCP1: how do fatty acids and nucleotides functionally compete to regulate the activity of UCP1 if they bind non-competitively?
Here we present the first demonstration that fatty acids change the conformation of UCP1.
Using two independent tests, fluorescently labeled nucleotide binding and controlled trypsinolysis, we show that palmitate significantly changed the kinetics of both of these processes. This finding eliminates arguably the most substantial intellectual roadblock towards acceptance of the functional competition model to describe the regulation of UCP1.
EXPERIMENTAL PROCEDURES
Animals-All animals were housed at 21 ± 2 °C with humidity 57 ± 5% and a 12 h light/dark cycle. Food and water were available ad libitum. Female Wistar rats were euthanized between ages 5-8 weeks by stunning and cervical dislocation. Wildtype and sibling paired Ucp1-null mice were derived as previously described (17,18). All animal care and procedures were in compliance with Principles of laboratory animal care (NIH publication # 85-23, revised 1996) under protocol #A10080 approved by the Buck Institute IACUC. When applicable, Home Office (UK) Guidelines for the Care and Use of Laboratory Animals were followed.
Mitochondrial isolation-Mitochondria from rodent BAT were isolated by differential centrifugation as described in (19) with all steps conducted at 4 °C. Briefly, inter-and subscapular BAT was excised and homogenized with a glass Dounce homogenizer in medium containing 250 mM sucrose, 5 mM Tris (pH 7.4 at 4°C), 2 mM EGTA, and 1% (w/v) defatted BSA. Mitochondria were washed at 700 g and collected at 8500 g.
Mitochondria from rodent thymus were isolated in a similar medium containing 0.5% (w/v) defatted BSA. They were washed at 1,000 g and collected at 11,600 g. Protein concentrations were determined using the Bradford method (20) for mitochondria from BAT or the biuret method (21) for mitochondria from thymus.
Proton leak kinetics-The proton leak rate was defined as the respiration needed to pump protons out of the mitochondrial matrix in nonphosphorylating mitochondria (19, 22) . Therefore, the proton leak kinetics were measured as the dependence of this proton leak rate on the mitochondrial membrane potential that drives it (15) .
Mitochondria from BAT (0.35 mg/mL) were incubated at 37 °C in 3.5 mL of assay medium containing 50 mM KCl, 5 mM HEPES (pH 7.2), 1 mM EGTA, 4 mM KH 2 PO 4 , and 1% (w/v) defatted BSA. Respiration was measured using a Clark-type electrode, and it was assumed the electrode buffer contained 406 nmol O/mL (23) . Mitochondrial membrane potential was measured using an electrode responsive to the lipophilic cation triphenylmethylphosphonium (TPMP + ). A TPMP + binding correction of 0.4 µL -1 . mg protein was applied according to (24) .
Prior to each experiment, the TPMP + electrode was calibrated with sequential additions of 0.5 µM TPMP + (up to 2.5 µM). Mitochondria were energized by the addition of 10 mM sn-glycerol 3-phosphate as substrate and, after 1.5 min, membrane potential was sequentially decreased with a cyanide titration (5-255 µM). The following compounds were included in each experiment: 5 µM rotenone (added to inhibit NADH:ubiquinone oxidoreductase, Complex I), 1 µg/mL oligomycin (an ATP synthase inhibitor added to ensure all proton conductance is due to leak), and 80 ng/mL nigericin (added to decrease the pH gradient). 0.6 µM FCCP was added after each experiment to release TPMP + from the mitochondria and allow baseline correction.
Fatty acid preparation-Albumin-buffered palmitate was prepared, and the free fatty acid concentration was calculated, according to (25) .
Nucleotide binding
BAT mitochondria were incubated at 2.5 mg/mL in medium identical to that used to measure proton leak kinetics. Mitochondria were exposed to a range of concentrations of 3 H-GDP or mant-GDP [2'-/3'-O-(N-methylanthraniloyl)-GDP, (26)] for 5 min. Non-specific binding was determined by running parallel samples in the presence of 3 mM unmodified GDP.
Following incubation with 3 H-GDP, samples were pelleted, resuspended in 20% (v/v) Triton X-100, placed in scintillation vials, vigorously mixed with scintillation fluid, and counted.
Following incubation with mant-GDP, samples were pelleted (16000 g for 5 min), washed with assay medium at 4 °C, solubilized in 1% (w/v) SDS, and briefly spun to remove insoluble material. Any mant-GDP specifically bound to UCP1 would be present in the soluble fraction, and was detected by fluorescence emission at 435 nm when excited at 350 nm. As such, fluorescence was used only as a directly proportional measurement of the amount of tagged GDP specifically bound to UCP1 (analogous to the 3 H-GDP measurements). Trypsinolysis-Freeze-thawed mitochondria from BAT (0.35 mg/mL in assay medium) and thymus (0.50 mg/mL in isolation medium) were subjected controlled, enzymatic proteolysis at 37 °C. Exogenous trypsin was added (300 µg/mg mitochondrial protein), and the reaction was quenched at defined times with excess trypsin inhibitor (1 mg/mL) at 4 °C.
Immediately upon trypsin inhibition, samples were pelleted and prepared for western analysis. Tween 20] . They were later exposed to a rabbit polyclonal primary antibody for UCP1 (Sigma U6382) at either 0.05 µg/mL (BAT) or 0.15 µg/mL (thymus) in blocking buffer and incubated overnight at 4 °C. After washing in TBST, membranes were incubated with a peroxidase-conjugated, goat anti-rabbit secondary antibody (Thermo Scientific; 31463) at 0.05 µg/mL in blocking buffer for 1 h. Densitometry analysis with ImageJ was used to quantify immunoblots (28) . Purified UCP1 was obtained from laboratory stocks, generated as described in (29) .
Statistics-Statistical significance was assessed by analysis of variance (ANOVA) for repeated measures with Dunnett's Post Test (95% confidence interval) using GraphPad Prism v. 5.0a. Binding parameters and curve fits were also calculated with this software. Values of p<0.05 (*) were considered statistically significant [p<0.01 (**)].
RESULTS
Using mant-GDP to study conformational changes in UCP1-The activation of UCP1 by fatty acids and its inhibition by nucleotides can be described by Michaelis-Menten kinetics with a competitive inhibitor (14) . However, fatty acids have little effect on the affinity or maximum binding of 3 H-GDP to UCP1 (9, 11, 16) . This apparent discrepancy between the functional and binding properties of the protein is a persistent hurdle, preventing a thorough description of the physiological mechanism and regulation of UCP1.
To address this issue, we used a fluorescently labeled guanine nucleotide analog, mant-GDP, to determine if fatty acids alter the binding of nucleotides to UCP1. The demonstration of such a change in nucleotide binding would imply a fatty acid-induced conformational change in UCP1, and would help explain how fatty acids can overcome nucleotide inhibition.
Tracking the mant moiety as a label-It is crucial to reiterate that the fluorescence of mant-GDP was used in the present study simply as a proportional indicator of how much nucleotide was bound to a given sample. Initial attempts to find a UCP1-specific signal by fluorescence resonance energy transfer (FRET) upon mant-GDP binding, as was done for purified UCP2 (30), were unsuccessful. In the present study, fluorescence from mant-GDP was measured only as a straightforward label of bound nucleotide in resolubilized mitochondrial pellets; the mant substitution can be thought of similarly to the tritium substitution on 3 H-GDP. Inhibition of proton conductance by mant-GDP-Prior to studying its binding to UCP1, it was necessary to verify that mant-GDP could inhibit proton conductance as effectively as unmodified GDP. Fig. 1a shows the classical activation and inhibition of proton conductance in mitochondria from BAT. As expected, the proton leak rate at any given mitochondrial membrane potential (Δψ m ) increased with the addition of 40 µM albumin-buffered palmitate. Addition of 30 µM GDP decreased the proton conductance in the absence of palmitate, and almost entirely inhibited the increase in proton conductance caused by addition of palmitate.
Figs. 1b and 1c show 30 µM mant-GDP was, indeed, an equally potent inhibitor of proton conductance as 30 µM unmodified GDP in either the absence (Fig. 1b) or presence (Fig. 1c) of exogenously added palmitate. We conclude that mant-GDP and unmodified GDP are functionally equivalent inhibitors of the proton conductance of UCP1.
Mitochondrial labeling with mant-GDPMitochondrial labeling with mant-GDP is insensitive to nucleotides that are not ligands of UCP1. Fig. 2a shows a fluorescence emission spectrum of mant-GDP released from BAT mitochondria after binding, centrifugation, and solubilization of the pellet. The amount of mant-GDP retained in the pellet was reduced in the presence of excess, unmodified GDP. The difference between these spectra represents specific mant-GDP binding.
The nucleotide specificity for UCP1 is welldocumented: it binds to, and is inhibited by, only purine nucleoside di-and triphosphates (31) . Importantly, neither excess GMP nor CDP reduced the amount of mant-GDP bound (Fig. 2a) , showing that mitochondrial labeling with mant-GDP was in accordance with the nucleotide specificity of UCP1.
Fatty acids enhance specific binding of mant-GDP-Upon finding mitochondria from BAT could specifically bind mant-GDP, a clear extension of the result was to determine if this binding could be altered by fatty acids. Fig 2b shows 515 nM free palmitate [1 mM palmitate buffered with 1% (w/v) BSA] significantly increased the amount of mant-GDP bound to mitochondria from BAT after incubation for 5 min.
Critically, palmitate only affected the specific binding of mant-GDP. Non-specific binding, calculated as the amount of mant-GDP bound in the presence of excess, unmodified GDP, was unaffected (Fig. 2b right) .
Although palmitate slightly increased the specific binding of mant-GTP, mant-ADP, and mant-ATP to mitochondria from BAT (not shown), a significant, pronounced increase was only seen with mant-GDP binding.
Fatty acid-enhanced binding is mediated by UCP1-To ensure that the palmitate-stimulated increase in mant-GDP binding was a genuine interaction between UCP1 and the nucleotide, two controls were required.
First, Fig. 2c shows that UCP1 was almost wholly responsible for this effect. In mitochondria from BAT of wild-type mice, specific mant-GDP binding was more than doubled in the presence of palmitate (Fig. 2c left) . This increase was almost entirely absent in mitochondria from BAT of Ucp1-null mice (Fig. 2c right) , where trace binding was likely attributable to ANT (32) .
Second, it was necessary to prove there was no specific interaction between UCP1 and the mant moiety attached to the nucleotide. Fig. 2d shows that GDP is the functional group responsible for mant-GDP binding. Substitution of GDP with a methyl group, resulting in dimethylanthranilate (DMA), which fluoresces similarly to mant-GDP, all but eliminated both the specific binding of mant-GDP and the increase in binding stimulated by palmitate.
The results from these two experiments lead to the following conclusion: the palmitate-stimulated increase in mant-GDP binding is exclusively due to UCP1 interacting with the nucleotide.
Competition between mant-GDP and 3 H-GDP-The discovery that palmitate changed the amount of mant-GDP bound to UCP1 is of particular importance because of the multiple, independent confirmations that fatty acids do not substantially change the ability of UCP1 to bind 3 H-GDP (9, 11, 16) . It was therefore necessary to verify that mant-GDP and 3 H-GDP both bound to the established nucleotide binding site in UCP1.
As expected, palmitate did not change the amount of 3 H-GDP bound to mitochondria from BAT (Fig. 3, left) . Fig. 3 (right) shows two significant effects when mitochondria were incubated with both mant-GDP and 3 H-GDP. First, a half-maximal concentration of mant-GDP [30 µM, (Table 1) ] decreased the specific binding of 3 H-GDP when mitochondria were incubated with a near maximal concentration of 3 H-GDP [100 µM (9, 33) ] in the presence of BSA. Second, the displacement of 3 H-GDP by mant-GDP was enhanced when palmitate was present in the medium.
Therefore, not only does mant-GDP bind to the classical nucleotide binding site of UCP1, but also the palmitate-stimulated increase in binding occurs at this site.
Affinities and maximum binding of mant-GDPUpon finding that fatty acids increased mant-GDP binding to UCP1, it was important to determine the mechanism by which this occurred. In principle, fatty acids could have increased the amount of nucleotide bound to UCP1 by changing either the apparent affinity of UCP1 for mant-GDP (K 0.5 ) or the maximum capacity of UCP1 to bind mant-GDP (B max ). Fig. 4a shows that palmitate substantially changed the apparent B max for mant-GDP. At any given concentration, palmitate increased the amount of mant-GDP specifically bound to mitochondria from BAT after a 5 min incubation. There was no decrease in K 0.5 ( Table 1) .
The observations that palmitate changed the B max of mant-GDP binding (Fig. 4a) , and that the palmitate-stimulated increase in binding occurred at the classical nucleotide binding site of UCP1 (Fig. 3) , led to the following hypothesis: mant-GDP binding to UCP1 is occluded in the absence of palmitate.
Comparisons of the binding of mant-GDP with 3 H-GDP supported this hypothesis (Fig. 4b ). As expected, palmitate again changed neither the K 0.5 nor B max of 3 H-GDP binding to UCP1 (Fig. 4b  triangles) . In stark contrast, palmitate had a dramatic effect on the ability of mant-GDP to bind to UCP1. When medium was lacking palmitate, the apparent maximum capacity of UCP1 to bind mant-GDP was severely restricted (Fig. 4b open  circles) . With palmitate present, however, B max was restored and the binding of mant-GDP was in line with that of 3 H-GDP (Fig. 4b closed circles, Table 1 ).
Physiological relevance of palmitate concentration-A significant change in nucleotide binding due to fatty acids has never before been reported for UCP1. Therefore, it was important to confirm that this effect could occur at physiologically relevant palmitate concentrations, since the experiments described above used saturating concentrations (515 nM) of free palmitate. Fig. 4c shows that physiologically relevant concentrations of palmitate stimulated an increase in mant-GDP binding. 35 nM palmitate was required for a half-maximal increase in mant-GDP binding, which falls between the reported values of 5 nM (14) and 80 nM (34) for the K 0.5 of fatty acid activation of UCP1.
Time-course of mant-GDP binding-How might palmitate restore the apparent maximum capacity of UCP1 to bind mant-GDP? A time-course of nucleotide binding revealed that palmitate changed the rate constant of mant-GDP binding to UCP1. Fig. 4d shows the longstanding result with 3 H-GDP binding: the timecourse of binding of this nucleotide to UCP1 (conducted on ice to slow the rate) was independent of the presence or absence of palmitate. However, Fig.  4e shows this was not the case for mant-GDP, as palmitate drastically increased the rate at which mant-GDP bound to UCP1 (conducted at room temperature to give higher rates). Without palmitate, mant-GDP eventually reached its maximum binding after 30 min. It was not, though, anywhere near its maximum at 5 min, the duration of the binding incubation used in the experiments described above.
We therefore conclude that palmitate induced a change (presumably conformational) in UCP1 that resulted in an increased rate constant for mant-GDP binding. Our results are consistent with the inability of previous studies to diagnose this conformational change using 3 H-GDP, as there was no change in any binding parameters for 3 H-GDP upon palmitate addition.
This finding has profound implications for the regulation and catalytic mechanism of UCP1. Therefore, it was important to use another method to independently confirm that palmitate induces a conformational change in UCP1.
Trypsinolysis of UCP1-Controlled enzymatic proteolysis has been used to correctly identify the topology of mitochondrial carriers (35) . This has been done for UCP1, and the technique can link the functional inhibition of UCP1 by GDP with a conformational change that protects lysine-292 from tryptic cleavage (36) . Therefore, a natural extension of the finding discussed above was to determine if trypsinolysis could detect a palmitateinduced conformational change in UCP1.
Selectivity and calibration of western analysisPrior to conducting trypsinolysis of UCP1, it was necessary to confirm that the analysis was both specific and appropriately calibrated. Fig. 5a shows that immunodetection of UCP1 was specific, as there was no signal in mitochondria isolated from BAT or thymus of Ucp1-/-mice. Furthermore, Figs. 5b and 5c show that a 4-5-fold, pseudo-linear range for western analysis existed using mitochondria and purified UCP1. No measurements were made subsequently outside of the range of protein concentrations shown in Fig. 5 (37). To ensure that the transfer events were reliable, two samples of mitochondria were collected prior to exogenous trypsin addition ("time = 0") and run on opposite ends of the SDS-PAGE gel (not shown). Each experiment was also conducted with five biological replicates.
Trypsinolysis of UCP1 in mitochondria from BAT-Figs. 6a and 6b confirm previous work showing that purine nucleotides protect UCP1 from tryptic cleavage at the C-terminus (36, 38) . Palmitate, however, significantly accelerated the rate of degradation of UCP1 in mitochondria from BAT. The exponential decay constant associated with UCP1 trypsinolysis was three-fold greater upon addition of 500 nM free palmitate (Fig. 6b) , indicating an acute, molecular interaction with palmitate that induced a conformational change in UCP1.
Trypsin initially cleaves UCP1 at K292, and the resultant UCP1 molecule lacking its Cterminus is historically called "T-1" (36, 38) . Preincubation of mitochondria from BAT with 500 µM GDP completely inhibited the formation of this species (Fig. 6a) .
Importantly, the accelerated degradation profile in response to palmitate also included the appearance of the T-1 product (Fig. 6a) . It can therefore be concluded that the conformation induced by palmitate, in direct contrast to GDP, made K292 more accessible to trypsinolysis. This conformational change was entirely inhibited when mitochondria were incubated with 500 µM GDP prior to the addition of 500 nM palmitate.
Measurements of cleavage of N-benzoyl-Larginine ethyl ester (BAEE) showed unperturbed signals in the presence of palmitate or GDP (not shown), indicating that the specific activity of trypsin was not compromised by these effectors. Moreover, no endogenous degradation was seen in the absence of trypsin over 2 h (not shown), suggesting palmitate was directly affecting the conformation of UCP1 and not stimulating endogenous proteolysis.
Trypsinolysis of UCP1 in mitochondria from thymus-Trypsinolysis of UCP1 expressed in thymus responded similarly to trypsinolysis of the protein expressed in BAT: (i) the protein was almost entirely protected by GDP, (ii) palmitate induced a conformational change that accelerated the rate of degradation, (iii) the hallmark T-1 band was present upon trypsin addition, and (iv) induction of this conformation was completely inhibited upon pre-incubation with GDP (Fig. 6c) .
DISCUSSION
Although fatty acids can overcome nucleotide inhibition in BAT mitochondria to activate UCP1, this functional competition has never been explained at the molecular level, as ligand binding experiments using 3 H-GDP have revealed little or no effect of fatty acids on nucleotide binding. Our results can resolve this apparent discrepancy.
We provide the first evidence that fatty acids change the conformation of UCP1: fatty acids increase the rate constant of mant-GDP binding and accelerate the trypsinolysis of UCP1. This conformational change provides the means by which fatty acids can overcome inhibition by nucleotides to activate UCP1.
At first, the observation that palmitate induces a conformation that promotes mant-GDP binding may seem counterintuitive, as fatty acids are activators of UCP1 activity and nucleotides are potent inhibitors. Rather, the observation strongly supports a model in which UCP1 broadly exists in two conformations: a "loose" proton conducting conformation and a "tight" inhibited conformation (36, 39) . The data show that 3 H-GDP can bind equally well to each conformation, but that mant-GDP strongly favors the "loose" conformation. Presumably, fatty acids facilitate mant-GDP binding by inducing an open, proton-translocating conformation that can better accommodate the bulky, substituted nucleotide. Such a model not only supports the existence of two conformations of UCP1, but can also accommodate a two-stage model for nucleotide binding (39, 40) .
Differential binding of modified nucleotides to UCP1 is not without precedent. For both mantand dansylated nucleotides, bulky substitutions attached to 2'-O-or 3'-O-of the ribose cause preference for different conformations of UCP1 depending on the nucleotide involved (40) .
Fatty acids did not significantly change the capacity of UCP1 to bind mant-ADP, mant-ATP, or mant-GTP. This reinforces two principal observations: first, the altered binding of mant-GDP is not due to a promiscuous reaction between fatty acids and the 'mant' moiety, and secondly, the conformational change promoted by fatty acids is rather subtle at the level of ligand binding. It accelerates mant-GDP binding but is not so pronounced that it alters the binding of 3 H-GDP or other mant-substituted nucleotide analogs.
The conformational change induced by fatty acids can also be diagnosed by controlled, enzymatic proteolysis. The protection from trypsinolysis afforded by GDP has previously been linked to a conformation of UCP1 that does not translocate protons. It is therefore likely that the conformation induced by palmitate, which accelerates tryptic cleavage, is protonophoric.
When the medium was supplemented with both 500 nM palmitate and 500 µM GDP, UCP1 was entirely protected regardless of the order of effector addition (not shown). Initially, this may seem more in line with UCP1 reconstituted into liposomes, where fatty acids cannot overcome nucleotide inhibition of proton translocation (16), rather than the functional competition seen in mitochondria (14) . No such determination can be made, though, without a proper titration of both effectors. The established K 0.5 values for nucleotides (9, 33) and fatty acids (14, 34) indicate that the concentrations used routinely in the present study were saturating for both.
The results obtained from trypsinolysis in mitochondria from thymus do more than simply corroborate the results from BAT. Foremost, they provide independent evidence to support the functional expression of UCP1 in the rodent thymus, which heretofore has only been shown by one research group (4, 5) .
Additionally, showing that fatty acids changed the conformation of UCP1 expressed in this tissue could be relevant to the evolutionary history of UCPs. It remains controversial as to whether UCP1 and its fatty acid activation evolved part and parcel with brown adipose tissue and nonshivering thermogenesis (41, 42) . At the very least, our demonstration that fatty acids can acutely activate UCP1 in mitochondria from thymus shows that fatty acid-activated uncoupling does not strictly imply a thermogenic function.
Emerging biophysical methods to study conformational changes in UCP1 could prove powerful provided expression in these systems exhibits regulatory properties similar to BAT (43) .
Although all three competing models of UCP1 activation can accommodate the demonstration that palmitate induces a conformational change in the protein, only the functional competition model explicitly suggests an allosteric change induced by fatty acids.
A conformational change is also compatible with evidence that fatty acids and nucleotides functionally compete to regulate UCP1 activity without fatty acids changing the binding of unmodified nucleotides. In principle, palmitate and GDP can compete to induce conformational changes in the protein to modulate activity with neither molecule preventing the other from binding to the protein. 
